IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro. - Wikidata - wikimedia - TriplyDB

IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro.

IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro.

http://www.wikidata.org/entity/Q40186472

about

STAT3, a Key Parameter of Cytokine-Driven Tissue Protection during Sterile Inflammation - the Case of Experimental Acetaminophen (Paracetamol)-Induced Liver Damage Hepatoprotective and anti-fibrotic functions of interleukin-22: therapeutic potential for the treatment of alcoholic liver disease Interleukin-22 in kidney injury and regeneration.Dexamethasone suppresses interleukin-22 associated with bacterial infection in vitro and in vivo rs1004819 is the main disease-associated IL23R variant in German Crohn's disease patients: combined analysis of IL23R, CARD15, and OCTN1/2 variants IL-22 is involved in liver regeneration after hepatectomy SOCS3 inhibits the pathological effects of IL-22 in non-melanoma skin tumor-derived keratinocytes Role of interleukin-22 in liver diseases.Comparative analysis of the lambda-interferons IL-28A and IL-29 regarding their transcriptome and their antiviral properties against hepatitis C virus.A Nationwide Study of Severe and Protracted Diarrhoea in Patients with Primary Immunodeficiency Diseases The role of chemokines in the recruitment of lymphocytes to the liver.Acute and chronic effects of IL-22 on acetaminophen-induced liver injury The role of osteopontin (OPN/SPP1) haplotypes in the susceptibility to Crohn's disease SOCS1, a Negative Regulator of Cytokine Signals and TLR Responses, in Human Liver Diseases.Highest frequencies of interleukin-22-producing T helper cells in alcoholic hepatitis patients with a favourable short-term course.IL22/IL-22R pathway induces cell survival in human glioblastoma cells.Redundant and pathogenic roles for IL-22 in mycobacterial, protozoan, and helminth infections Cytokines and STATs in Liver Fibrosis.Interleukin 31 mediates MAP kinase and STAT1/3 activation in intestinal epithelial cells and its expression is upregulated in inflammatory bowel disease.Cooperation between the bacterial-derived short-chain fatty acid butyrate and interleukin-22 detected in human Caco2 colon epithelial/carcinoma cells.Aberrant expression of IL-22 receptor 1 and autocrine IL-22 stimulation contribute to tumorigenicity in ALK+ anaplastic large cell lymphoma.Interleukin-22 contributes to liver regeneration in mice with concanavalin A-induced hepatitis after hepatectomy.Th17 cells and their associated cytokines in liver diseases.IL-22 secreted by decidual stromal cells and NK cells promotes the survival of human trophoblasts.Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases.Th17 cell cytokine secretion profile in host defense and autoimmunity.IL-22: An Evolutionary Missing-Link Authenticating the Role of the Immune System in Tissue Regeneration.IL-22 in tissue-protective therapy.Cytokine-Mediated Immunopathogenesis of Hepatitis B Virus Infections.Biological and pathological activities of interleukin-22.Interleukin-6 inhibition of peroxisome proliferator-activated receptor alpha expression is mediated by JAK2- and PI3K-induced STAT1/3 in HepG2 hepatocyte cells.Polymorphisms in interleukin-10 and interleukin-28B genes in Egyptian patients with chronic hepatitis C virus genotype 4 and their effect on the response to pegylated interferon/ribavirin-therapy.Up-regulated Reg proteins induced by Interleukin-22 treatment ameliorate acute liver injury in rat model.IL-22 and IL-22 binding protein (IL-22BP) regulate fibrosis and cirrhosis in hepatitis C virus and schistosome infections.Interleukin 22 signaling promotes cell growth in mantle cell lymphoma.The role of IL-22 in the resolution of sterile and nonsterile inflammation.IL-22 sustains epithelial integrity in progressive kidney remodeling and fibrosis

P2860

Q26747404-F4361AE2-6E0E-42D8-B10D-16CFDAE0B168 Q27027380-8FF592C8-B83D-4D15-883C-E8D6B5E97724 Q27687335-FBF3CB67-4B71-4AFE-9798-FA37472ADEF0 Q28573335-55A4BFBF-E694-42A3-808C-23784191F686 Q33296981-8FEEA19C-7FBB-4BA5-9190-E3308E1C8281 Q33589028-8F408FDC-B43B-4840-BEB4-D835A6FF4974 Q33648604-7B524CE5-E812-4816-BBF6-F8F0F48DB8B2 Q33729412-CAE1E5B1-A158-4776-B865-BBFE893FC9A8 Q33775597-2E338AEC-0F67-4673-A7CD-F6A422236C9E Q33808099-422BAA92-1208-4E3E-A77B-D769F653A617 Q33906565-F4DF3D52-44D8-4079-8CB0-3D9EE06F230E Q34054086-C4A5DDE4-14DD-4996-A80F-5E28F2B90928 Q34126426-BCD8636C-2420-4495-9FF5-8759CEDD22B6 Q34127568-53578F1F-43E6-42CD-81A6-2BF96545BA65 Q34571578-BF326177-8E95-4A83-9617-FCE64DA3B638 Q35203455-B0FCBB01-9386-437F-AA84-567A80D196C8 Q35205539-7285FC3A-A8E0-4878-8B51-02D204EA0CE9 Q35867085-C136E55A-E86D-44B5-8053-5772CD42AED1 Q35954120-BD8DF0B5-6CB4-4F59-AE5F-BCC613389810 Q36179133-B24E8774-56FC-409B-92E3-5361A3270D1D Q36193920-3CFAB6B2-66AB-4447-9CCA-F4147D8D392B Q36501689-D16319BC-4CCA-478F-87D0-3C58B805A9DF Q37067749-8DBD6D9B-6943-4B92-BD0C-66304AB18078 Q37137988-616B40B3-FEEC-4CA8-B34F-C8C608CFEF15 Q37326768-91A00D61-0E13-49AC-8275-E59E91818FDA Q37971256-18387BA1-7DF2-4182-A8CC-8829AD62AF02 Q38079587-5C153A8A-C725-4EAB-9770-86F9B9FD4585 Q38093227-72F0EFC9-9955-403F-9D2F-03E13E4EA08E Q38283963-5D46FFB6-41F5-4122-A05E-A080EB3175BD Q38753752-C131C94A-0D53-40A4-AC96-C829EEB1F41F Q39062248-CA005DFA-7ECC-4981-8AD9-7FB9A7C27111 Q39450494-D32D9481-1AF4-458D-8911-894079865FA6 Q41416579-6223FC65-5103-411D-8606-6E1EFE6F0042 Q41616535-10727B6F-4BBA-4D3C-9178-E31944E86755 Q42580235-1251A094-35CF-456C-8B07-3C4B83C7F43F Q54224246-B466EDD3-70AA-4E11-9263-6A28A2BA0AD8 Q58699771-ED9A4A40-69DE-447B-95CC-5CE030DB7948

P2860

IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro.

http://www.wikidata.org/entity/Q40186472

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro.

@en

type

label

IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro.

@en

prefLabel

IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro.

@en

P1433

Q40186472-8EFF99D7-A6F6-40BE-90E0-33CE4B4F8E50

P1476

Q40186472-DCDF6F61-1739-4876-9CD1-E69E2A1A4961

P2093

Q40186472-1D514571-4692-4589-ABDE-1610A1F0F3FE

Q40186472-25A1E41F-965B-4ADC-8C9B-3B04A21182FB

Q40186472-2DDAE26C-187D-45EC-A9BC-5976056C91C4

Q40186472-3698E17F-B9D2-4F4F-AD0F-EB809BABFB1F

Q40186472-506096DE-9090-4981-93C1-3657B79F56F5

Q40186472-552EF67F-3BEF-4F76-A67C-F05C52DFE175

Q40186472-570BAC43-28A5-44FC-BCCA-2D3D71699782

Q40186472-6D77E099-B448-41B5-B803-7C6B27D01306

Q40186472-823C85CB-E3F3-4D50-BDCC-0E0E3592E1A1

Q40186472-A6051160-3F78-4D7C-A4E2-F0AD958C890D

P2860

Q40186472-01E307CE-5271-4D9E-8DD9-A70D48C9E240

Q40186472-043E10D2-DAB8-4176-ADA6-4FA0DB43EABC

Q40186472-0B9DF1E2-F603-4144-ADD5-C8E1D4B8E80D

Q40186472-22382ADC-A596-4E6F-8CA2-BA2F2D92F77C

Q40186472-2A3672FC-DACD-4152-9FC5-97738CD5FB3F

Q40186472-32629765-E38E-4A78-A631-549A75CAFFC4

Q40186472-38134C38-4CF9-4BC4-809B-144530860ACE

Q40186472-39410661-EE50-4C2E-8121-9A0245CDAF7D

Q40186472-3D0F842E-F42D-4AA5-849A-495126E6EB36

Q40186472-3D7879B5-43BD-4554-B058-B308A1D8B605

P304

Q40186472-3F0DAE28-3675-47EE-9AE4-584452BABB0E

P31

Q40186472-6B3CD9EA-2B25-4E4F-86BA-04E0C088AC6D

P356

Q40186472-3A459192-86D7-463D-BF3D-B60C75C597E2

P433

Q40186472-2CB5D6D0-72D0-4C83-9B93-FA9B4375F0BC

P478

Q40186472-50A3BAEE-43DB-43DE-9E53-8CD2A9A831A4

P50

Q40186472-DC33FCD8-BF8E-42C5-B8F3-E1EC9563E354

P577

Q40186472-15FCC47D-1998-4349-92B0-D3F657AA8A8B

P5875

Q40186472-BCBF7B92-DF80-4AA9-BCAA-D15935D69296

P698

Q40186472-7B491A0E-7834-449E-B98A-5023458209CE

P921

Q40186472-9DE98862-DC98-47A2-A3FB-87D4EF52F36E

P356

AJPGI.00239.2006

P1433

American Journal of Physiology - Gastrointestinal and Liver Physiology

P1476

IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro.

@en

P2093

Burkhard Göke

http://www.w3.org/2001/XMLSchema#string

Christian J Steib

http://www.w3.org/2001/XMLSchema#string

Christoph J Auernhammer

http://www.w3.org/2001/XMLSchema#string

Florian Beigel

http://www.w3.org/2001/XMLSchema#string

Helmut Diepolder

http://www.w3.org/2001/XMLSchema#string

Julia Dambacher

http://www.w3.org/2001/XMLSchema#string

Kathrin Zitzmann

http://www.w3.org/2001/XMLSchema#string

Malte H J Heeg

http://www.w3.org/2001/XMLSchema#string

Manfred Bilzer

http://www.w3.org/2001/XMLSchema#string

Martin Storr

http://www.w3.org/2001/XMLSchema#string

P2860

Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R

Identification, cloning, and characterization of a novel soluble receptor that binds IL-22 and neutralizes its activity

Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway

SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2

Fractalkine-mediated signals regulate cell-survival and immune-modulatory responses in intestinal epithelial cells

The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain

IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression

IL-22 increases the innate immunity of tissues

Expression of suppressors of cytokine signaling during liver regeneration

Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms

P304

G1019-28

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPGI.00239.2006

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

292

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-01-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6595703

http://www.w3.org/2001/XMLSchema#string

P698

17204547

http://www.w3.org/2001/XMLSchema#string

P921